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As the second leading cause of cancer death worldwide, colorectal cancer (CRC) poses a 
significant threat to both men and women alike. Although a small percentage of CRC cases are 
inherited, the majority of cases arise from environmental causes and are widely attributed to 
dysfunctional cellular pathways.  Currently, the CRC progression model maintains that cancer 
growth, relapse and metastasis are due primarily to cancer stem cells (CSCs), a cell subpopulation 
that shares many properties with stem cells through epithelial to mesenchymal transition (EMT). We 
have recently reported that Notch-1 signaling is highly associated with promoting cancer stemness 
and EMT in CRC.  Furthermore, we observed that expression of the Notch-1 receptor also 
upregulates Jagged-1, a ligand of the Notch receptors, which may affect stemness and EMT. 
However, this effect is reversed by treatment with DAPT, a γ-secretase and Notch signaling inhibitor. 
Thus, we hypothesized that the effect of Notch-1 on stemness and EMT in CRC is mediated by 
Jagged-1 via another member of the Notch pathway, the Notch-3 receptor. 
To assess our hypothesis, we utilized the colon cancer cell line HCT-116. The parental HCT-
116 cells were transduced with an IRES (internal ribosome entry site)-GFP retrovirus that expressed 
the human intracytoplasmic domain of Notch-1, thus producing the ICN1 cell line.  The ICN1 cells 
were then transduced with a small hairpin RNA (shRNA) construct that effectively knocked down 
Notch-3, which created the ICN1-shN3 cell line. Growth ability, plating efficiency and colosphere 
 
	  
formation were assessed in each cell line.  In these experiments, cell culture and Western blot 
analysis were performed using standard methodology.  
We found that targeting Notch-3 via shRNA transduction in the colon tumor cell line ICN1-
shN3 resulted in a significant decrease of Notch-3 expression.  Further Western blot analysis 
indicated reduced expression of CD44 and Slug, markers for stemness and EMT, respectively.  
Further analyses showed that in the absence of functioning Notch-3, plating efficiency decreased by 
60% and migration decreased by 22% when compared to the ICN1 cell line.  These results were 
accompanied by significant changes in colosphere formation when the ICN1-shN3 cells were 
compared to ICN1 cells.  ICN1-shN3 cells showed a 35% reduction in colosphere formation 
compared to the ICN cells.  This difference was observed in colospheres of both high (33%) and 
medium/low (37%) proliferative capacity.  
These data indicate a key role for Notch-3 signaling in Notch-1-induced tumorigenesis 
mediated by Jagged-1.  They also highlight the potential use of Notch-3 inhibitors to effectively 
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CRC Incidence, Risk Factors, and Treatments 
Each year, roughly 1.2 million people are diagnosed with colorectal cancer (CRC) 
worldwide (American Cancer Society (ACS), 2014).  Of these patients, over 600,000 will die 
from the disease (ACS, 2014).  Since the mid-1980s, CRC incidence has steadily decreased 
(ACS, 2014).  Among those diagnosed with CRC, the overall survival rate has increased, 
reaching as high as 65% in some developed countries and 50% in undeveloped countries 
(Brenner et al., 2014).  The declines in CRC incidence and mortality over the past decade are 
largely due to frequent sigmoidoscopy and colonoscopy screening procedures, which permit 
detection and removal of precancerous polyps (Vinson et al., 2015).  If left untreated, non-
cancerous polyps can develop into cancerous lesions (Brenner et al., 2014).  
There is a broad spectrum of risk factors that lead to the development of CRC, including 
sex, age, lifestyle, diet, and medical and family history (Vinson et al., 2015).  The disease affects 
30-40% more men than women (ACS, 2014).  In 90% of patients, the onset of CRC occurs after 
the age of 50, and the median age at the time of diagnosis is 70 years (ACS, 2014).  The risk of 
developing CRC is greater in those individuals who have conditions such as inflammatory bowel 
disease, diabetes, or obesity (ACS, 2014).  Risk of CRC is also elevated in those who smoke, 
consume alcohol excessively, are physically inactive, or eat large amounts of red or processed 
meat (Vinson et al., 2015).  Although up to 35% of CRC cases may have a heritable component, 
only a small fraction (<5% of cases) can be attributed to a well-defined, inherited genetic 
mutation (Brenner et al., 2014). Thus, for the vast majority of patients with inherited CRC, the 
specific mechanisms of inheritance are unclear (Brenner et al., 2014).   
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Fortunately, modern medicine and lifestyle changes have been shown to reduce one’s risk 
of CRC by as much as 30% (Brenner et al., 2014).  These beneficial lifestyle changes include 
increased physical activity, taking aspirin regularly, hormone replacement therapy, and regular 
screening for precancerous lesions (Brenner et al., 2014).  Following a diet that is rich in fruit, 
vegetables, fiber, whole grains, dairy products, fish, and Vitamin D may also offer a slight 
protective effect (Brenner et al., 2014).      
Cancerous lesions in the large intestine develop over a period of roughly 10 years (ACS, 
2014).  Lesions begin as non-cancerous polyps on the inner lining of the intestine and most 
commonly arise from the adenomatous tissue 96% of the time (ACS, 2014).  Although fewer 
than 10% of non-cancerous polyps will develop into cancerous lesions, the likelihood that a 
polyp will become cancerous increases as it grows larger (ACS, 2014).    
Current treatments for CRC include combination chemotherapy, surgery, radiation, and 
some targeted therapies (Vinson et al., 2015).  Because CRC arises from the dysregulation of 
certain signaling pathways, identifying these pathways and their specific mechanisms is the key 
to creating more effective treatments for CRC patients (Vinson et al., 2015).  Once cellular 
pathways are further understood, small molecule inhibitors that function by directly targeting 
aberrant signaling pathways can prevent cancer progression. Such inhibitors, in combination 
with chemotherapy and surgery, can provide better outcomes for patients with CRC. (Vinson et 
al., 2015).   
In the field of oncology, tumorigenesis has been a significant topic of study for many 
decades.  In 1985, a study that collected data from various tissue samples proposed that most 
colorectal carcinomas arise from adenomas, which increase in size, dysplasia, and degree of 
villous morphology over a period of 10 years (Sugarbaker et al., 1985).  Five years later, a 
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different group developed the Vogelstein model, which identifies four distinct components of 
CRC tumorigenesis.  The first of these proposed that colorectal tumors develop as a result of 
mutational activation of oncogenes and pronounced increases in mutational deactivation of 
tumor suppressor genes (TSGs).  Second, malignant tumor formation requires more than one 
mutation at a single gene.  Third, the summation of the mutations (Ras oncogene mutations and 
chromosomal deletions), not the order of mutations, determine the tumor’s biological fate.  
Finally, not all of the TSGs will act in an autosomal recessive manner (Vogelstein & Fearon, 
1990).    
 
Epithelial Development of the Colon 
        In the inner lining of the large intestine (also known as the intestinal mucosa), the basic unit 
of structure is the crypt (Fig. 1).  The base of each crypt is composed of undifferentiated 
intestinal stem cells (ISCs) and progenitor cells, both of which are crucial for self-renewal. 
Formation of differentiated daughter cells compose the epithelial lining of the intestine.  As the 
cells divide and grow from the lower stem-cell region, they move up the crypt into the 
proliferative zone, where they are then classified as transit amplifying cells.  Because they divide 
twice daily, transit-amplifying cells are responsible for the rapid replacement of the intestinal 
epithelium.  Further differentiation occurs as the transit-amplifying cells ascend to the upper-
most portion of the crypt known as the differentiative zone, where they ultimately differentiate 
into goblet cells, enterocytes and neuroendocrine cells.  When cells reach the lumen of the large 
intestine, they are eventually shed and undergo apoptosis.  This continuous process is controlled 
by the crypt’s stem cells and gradients formed from various signaling pathways (Vinson et al., 










Figure 1.  Colon Anatomy and Signaling in the Crypt of Liberkuhn 
The figure shows the overall structure and components of the human colon crypt.  The presence 
of signaling pathways WNT, Notch, HH, and BMP is shown.  The differentiative, proliferative 




























        The cycle of continuous epithelial replacement is tightly controlled by a gradient of 
signaling pathways present in the crypt, which include WNT, Notch, BMP, and Hedgehog (HH) 
(Vinson et al., 2015).  Of these, Notch signaling pathway is most notable in the stem cell 
compartment at the base of the colon crypt.  In this region, proper Notch signaling is imperative 
to the proper differentiation, proliferation, and eventual apoptosis of epithelial cells (Previs et al., 
2015).  When dysregulated, the Notch pathway has been implicated in many cancers, including 
CRC (Medema and Vermeulen, 2011).   
The Notch Pathway  
	  
In the human body, the Notch signaling pathway (Fig. 2) is composed of five ligands and 
four receptors (Vinson et al., 2015). The ligands, named Jagged-1, Jagged-2, Delta-like-1 (Dll-
1), Delta-like-3 (Dll-3), and Delta-like-4 (Dll-4), are single-pass transmembrane proteins that 
contain epidermal growth factor (EGF)-like repeats (Vinson et al., 2015).  The four receptors of 
the pathway, named Notch-1, Notch-2, Notch-3 and Notch-4, are initially synthesized as protein 
precursors, or “pre-Notch” receptors (Al-Hussaini et al., 2011).  As development of the receptor 
continues, pre-Notch receptor proteins are fucosylated by the chaperone O-fucosyltransferase 
(O-Fut) in the endoplasmic reticulum (Fig. 2a) (Vinson et al., 2015).  It then enters the golgi 
apparatus, where Fringe glycosyltransferases (Lunatic, Manic and Radical) extend the O-fucose 
moieties and modify the receptor for interaction with a specific ligand (Fig. 2b) (Vinson et al., 
2015).  The receptor remains in the golgi while a proteolytic cleavage by a Furin-like protease at 
site 1 (S1) occurs, which heterodimerizes the Notch receptor (Fig. 2c) (Vinson et al., 2015).  In 
the last stage of synthesis, the mature Notch receptor is targeted to the cell membrane where it is 











Figure 2 (a-f).  The Notch Signaling Pathway and its Effect on the Activation of Target Genes  
Pre-Notch first undergoes fucosylation by O-fut (O-fucosyl transferase) in the ER (A), then is 
glycosylated and cleaved (S1 cleavage) by a furin convertase in the trans-golgi (B).  The 
heterodimeric receptor is assembled on the cell surface, where it is available for ligand binding 
(C).  Upon ligand binding, Notch undergoes S2 cleavage on the outer plasma membrane by 
ADAM (a disintegrin and metalloproteinase) and S3 cleavage at the inner plasma membrane by 
gamma-secretase, and then is transported to the nucleus where it activates transcription of DNA 
(D).  CoR (co-repressors) are displaced by ICN and transcription proceeds by CSL (CBF1, 
suppressor of hairless, Lag-1), MAML (mastermind-like proteins), HAT (Histone acetylase 
complex) and p300 (E).  Notch signaling is terminated when the ICN is targeted for degradation 





















The Notch receptors are transmembrane proteins with two distinct domains: extracellular 
and intracellular (Fig. 3) (Vinson et al., 2015). The extracellular domain contains variable 
numbers of EGF-like repeats, which permit binding affinity of particular ligands (Vinson et al., 
2015).  Notch receptors differ in their number of extracellular EGF-like repeats; Notch-1 and 
Notch-2 contain 36 repeats, Notch-3 contains 34 repeats, and Notch-4 contains 29 repeats 
(Ntziacristos et al., 2014).  All Notch extracellular domains contain three LNR (LIN-12/Notch-
related) residues that prevent ligand-independent signaling, as well as two cysteine residues (Al-
Hussaini et al., 2011).  The intracellular domain of the Notch receptor (ICN) functions as a 
transcriptional activator, and consists of ankyrin repeats, a RAM (Rbp-associated molecule) 
domain, a TAD (transactivation domain), an NLS (nuclear localization signal), and a PEST 
(proline-, glutamate-, serine-, and threonine-rich) domain that is responsible for the stability of 
proteins and the facilitation of rapid proteolytic degradation (Bertrand et al., 2012).  Although 
the four Notch receptors differ slightly in structure and possess specific ligand affinities, they 
operate using the same basic signaling pathway (Al-Hussaini et al., 2011).  
Notch signaling is activated when a Notch ligand binds to its Notch receptor.  This begins 
a sequence of two proteolytic cleavages of the Notch receptor (Fig. 2) (Vinson et al., 2015).  
Notch is first cleaved by ADAM (A disintegrin and metalloprotease) 10/17 directly outside the 
cell membrane at ‘site 2’, which removes Notch’s extracellular domain (Vinson et al., 2015).  
The remaining intracellular portion of the Notch receptor is referred to as the NEXT (Notch 















Figure 3:  The Notch Family Receptors.   
Notch-1, -2, -3, and -4 receptors shown with their various components.  EGF:  epidermal growth 
factor; LNR:  Lin Notch repeat; RAM:  Rbp-associated molecule; PEST:  peptide sequence of 

























The NEXT domain is subsequently cleaved at the inner cell membrane, ‘site 3’ (S3), 
freeing the ICN, which then translocates to the nucleus (Fig. 2d) (Vinson et al., 2015).  In the 
nucleus, ICN engages with DNA-binding proteins to regulate gene expression and initiate 
transcriptional events (Bertrand et al., 2012).  ICN first binds to an inactive CSL (CBF-
1/Suppressor of hairless/Lag-1) transcription factor (Vinson et al., 2015).  Coactivators, 
including mastermind-like proteins, p300, and the histone acetyl transferase complex (HAT), 
displace the co-repressors (Co-R) that are bound to CSL, which transforms the ICN-CSL 
complex into a transcriptional activator (Karamboulas and Ailles, 2013).  The downstream 
targets of the transcription include cell-fate regulators of the HES and HEY families, which are 
composed of a basic domain (determining DNA-binding specificity), and a helix–loop–helix 
domain (allowing for dimer formation) (Aithal and Rajeswari, 2013).  The dimerization of HES 
and/or HEY proteins regulates the transcription of key genes involved in apoptosis, cell cycle 
regulation, proliferation and differentiation, neurogenesis, and metabolism (Al-Hussaini et al., 
2011).  
A new cycle of Notch signaling begins after the synthesis of the pathway’s targets has 
occurred (Vinson et al., 2014).  At this time, ICN is phosphorylated by CDK8 (cyclin-dependent 
kinase 8) on its PEST domain (Fig. 2e) (Schwanbeck, 2015).  The phosphorylation allows 
ubiquitination by the E3 ubiquitin ligase Fbw7 (F-box and WD repeat domain-containing 7), 
followed by proteosomal degradation (Vinson et al. 2015).  Ultimately, the phosphorylation and 
ubiquitination of the ICN terminate Notch signaling, and the cell is reset to begin a new cycle. 






The Role of Notch Signaling in CRC 
	  
Dysregulation of the Notch pathway is commonly associated with many cancers.  
Aberrant Notch signaling was first identified in Leukemia, specifically T-cell Acute 
Lymphoblastic Leukemia (T-ALL) (Bertrand et al., 2012).  In T-ALL, Notch-1 was found to be 
constitutively activated upon fusing to the T-cell receptor B-locus (Bertrand et al., 2012). Later 
research demonstrated that mutations in Notch-1 are highly prevalent among T-ALL patients, 
further implicating the oncogenic role of Notch-1 (Bertrand et al., 2012).   
Depending on the specific microenvironment, the Notch receptors can act as both 
oncogenes and tumor suppressors.  It is widely recognized that upregulated levels of Notch-1 and 
Notch-3 are associated with cancer progression, tumor metastasis and inhibition of apoptosis 
(Vinson et al., 2015).  However, unlike Notch-1, the upregulation of Notch-2 is associated with 
better clinical outcomes (Vinson et al., 2015).  Thus, it is clear that the diverse functions of the 
Notch receptors contribute in contradicting ways to the progression of CRC (Bertrand et al., 
2012). 
Cancer Stem Cells 
The differentiating cells of the intestinal crypt are dependent upon the tight regulation of 
signals arising from the supportive mesenchymal cells and the extracellular matrix (ECM).  The 
crypt’s stem-cell compartment is predominantly regulated by Notch signaling, and deviations 
from its canonical pathway may contribute to the development of CSCs.  In the colon, intestinal 
stem cells (ISCs) drive the regeneration of normal intestinal epithelium, and it is proposed that 
CRC shares this model of cell development and reproduction, where CSCs are responsible for 
tumor growth and proliferation (Bertrand et al., 2012).  When Notch signaling in the crypt is 
dysregulated, an accumulation of mutations may result, promoting the development of CSCs, 
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and likely CRC.  CSCs are defined by their ability to self-renew, expand and differentiate.  
Overall, it is imperative to further understand the signaling and regulation involved in CRC 
development and maintenance in order to improve the therapies and prognosis for CRC patients 
(Medema and Vermeulen, 2011).     
 
Epithelial-to-Mesenchymal Transition  
	  
Recent studies have shown that metastasis of CRC is driven by Notch signaling through a 
process known as EMT (Zhao et al., 2015).  During EMT, epithelial cells undergo a 
developmental switch, resulting in decreased adhesion, loss of cell polarity, increased 
proliferation, and motility.  EMT is a normal process in some systems; the ability of various 
species to develop highly specialized tissues and organ systems is the result of increased 
differentiation of mesenchymal cells through EMT. Thus, many of the pathways involved in 
EMT are highly conserved and essential for development across different species (Lindsey and 
Langhans, 2014).    
However, the benefits of EMT in organismal specialization have been challenged by 
EMT’s role in the metastasis of certain carcinogenic tumors.  Increased proliferation, motility, 
and invasion are key steps towards progression of a malignant phenotype, which occurs as tumor 
cells translocate from the initial lesion into neighboring tissues.  Phenotypically, the cells change 
from a cuboidal, epithelial cell to a spindle-shaped mesenchymal cell (Lindsey and Langhans, 
2014).  
As EMT progresses, the cell surface changes dramatically.  Generally, cells are 
dependent upon the extracellular matrix and cell-cell interactions for survival.  When anchorage-
dependent tumor cells become detached from the surrounding extracellular matrix, the signals 
15 
	  
indicating cell survival cease, and a programmed cascade of events ends in cell death.  Some 
cells that become detached from the ECM, thus losing the cell-survival signals, still manage to 
survive by evading the programmed death.  This series of events leads to eventual metastasis 
(Heerboth et al., 2015).   
In order to begin migration, the cells must alter their characteristics from epithelial to 
mesenchymal, down-regulate the receptors that aid in cell-cell attachment, and up-regulate cell 
adhesion molecules for movement.  E-Cadherin, a transmembrane protein that anchors adjacent 
cells to each other forming adherens junctions, is lost.  Snail, Zeb and Twist are known as E-
Cadherin silencers/repressors.  The loss of E-Cadherin and adherens junctions are pivotal steps in 
EMT and the key to metastatic migration of cells (Heerboth et al., 2015).  This migration is 
facilitated by transcription factors Snail, Twist, Slug, Zeb, N-cadherin, and others.  Successful 
metastasis involves not only the ability of a cell to migrate from their tissue of origin; the cells 
must then regain their epithelial characteristics in order to take root and begin differentiation in 
the secondary tissue (Fig. 4) (Heerboth et al., 2015). 
Transcription factors Slug, Snail and TGF-β interact with the Notch pathway in a way 
that is critical for the process of EMT.  Notch is of particular interest in CRC research because its 
signaling is prominent in the stem cell compartment of the colon crypt and has extensive relation 
to EMT transcription factors (Vinson et al., 2015).  
 
Previous Work 
It has recently been reported that Notch-1 signaling is highly associated with the 
promotion of cancer, stemness and EMT in CRC.  Previous research indicates that constitutively 
activating the intracytoplasmic domain of the Notch-1 receptor in CRC cells (ICN1 cells) 
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resulted in the increased expression of Jagged-1, a ligand of the Notch pathway (Fender et al., 
2015).  In turn, the activation of Jagged-1 increases the expression of CD44 and Slug (Fender et 
al., 2015).  This model is shown in Figure 5.   
Since induction of stemness and EMT induced by Jagged-1 in parental CRC cells was 
blocked by DAPT, we assessed the expression of the Notch-2, -3, and -4 receptors in the 
presence of the ligand.  We found that the Notch-3 receptor was highly upregulated when HCT-
116 cells were cultured in plates coated with purified Jagged-1 (Fig. 6).  However, expression of 



























Figure 4.  The Role of CSCs in Metastatic Colonization.   
The CSC model is a proposed theory for carcinogenesis.  Formation of a primary tumor occurs 
and eventually begins to invade surrounding tissues.  CSCs undergo the process of EMT and 
enter the circulatory system via intravasation.   Eventually, CSCs leave the bloodstream via 
extravasation and migrate to distant tissues.  In the final stage of metastasis, CSCs undergo 


























Figure 5.  Previously Proposed Model.   
Notch-1 signal upregulates Jagged-1, which in turn activates another Notch-receptor species (that 
























































Figure 6.  Jagged-1 Upregulates Expression of the Notch-3 Receptor in CRC cells.   
Proteins from whole cell lysate were analyzed with Western blot analysis from the HCT-116 cell 










































Based on our previous findings, we hypothesized that Notch-1 receptor signaling 
promotes EMT, stemness, and tumorigenesis via activation of the Notch-3 receptor in colorectal 





















MATERIALS AND METHODS 
Cell Lines and Culture 
	  
All cells were plated and grown in T-25 culture flasks and incubated at 37.0oC with 4.0% 
CO2.  The flasks contained McCoy’s Media (Life Technologies, Carlsbad, CA) supplemented 
with 10% fetal bovine serum (FBS) (Atlanta Biologicals, Flowery Branch, GA) and 1% 
Penicillin-Streptomycin (Life Technologies).  When confluent, the cells were passaged using 
1xTrypsin/EDTA (ethylenediamenetetraacetic acid) (Life Technologies), and washed using 
Dulbecco’s phosphate-buffered saline (Life Technologies).   
Multiple cell lines were developed from the parental cell line, HCT-116 (ATCC, 
Manassas, VA), which are derived from human epithelial colorectal carcinoma cells of an adult 
male.  This cell line containing a functional Notch pathway is capable of tumorigenesis, and can 
also function as a transfection host.   
A cell line that constitutively expressed the intracytoplasmic domain of the Notch-1 
receptor (ICN1) was derived from the parental HCT-116 cells.  The ICN1 cell line was generated 
by transducing HCT-116 cells with an IRES-GFP retrovirus that contained the human ICN1 
(Fig. 7a).  The retrovirus was packaged by co-transfection with a plasmid that expressed the 
amphotropic viral coat.  The viral particle of interest, packaged in the supernatant, was collected 
and plated over HCT-116 cells.  Following this transfection, FACS (fluorescence-activated cell 
sorting) was used to collect those cells that simultaneously expressed the GFP-vector and the 
constitutively active ICN1.  HCT-116 cells were also transduced with the empty IRES-GFP 
vector.  Cell sorting was used to identify those cells expressing the GFP-vector alone (GFP-V 





















Figure 7.  Creation of the Experimental CRC Cell Lines.   
HCT-116 cells were transduced with an IRES-GFP retroviral construct expressing the human 
intracytoplasmic domain of Notch-1 (ICN1) and the green fluorescent protein (GFP) gene (A). The 
ICN1 cells were transduced with a small hairpin RNA construct that effectively knocked down 
Notch-3 and created the ICN1-shN3 cell line. Notch-3 null cells were selected in the presence of 
Puromycin. Cells expressing GFP (R1 region) were separated from cells lacking GFP expression 
to enrich the HCT116-ICN1 (ICN1) and the HCT-116-ICN1-shNotch3 (ICN1-shN3) cell lines 










Figure 7.  Creation of the Experimental CRC Cell Lines 
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  In order to further identify the role of the Notch-3 receptor in the Notch signaling 
pathway, expression of the Notch-3 receptor was knocked down within the ICN1 cell line.  
Notch-3 shRNA lentiviral particles (Santa Cruz, Dallas, TX) were used to target the Notch-3 
receptor for knockdown gene expression in the ICN1 cells as per manufacturer.  For the 
transfection, 6µl shRNA duplex was diluted into 100 µl of transfection medium, and this solution 
was added to the shRNA transfection reagent provided.  The ICN1 cells were incubated with the 
transfection reagent/medium solution for 24 hours.  The cells’ resistance to puromycin (1 µg/mL) 
was tested, and those cells surviving were further cultured.  Because these new cells also 
expressed ICN1, the GFP-vector was selected by FACS.  Specifically identifying the cells that 
were Puromycin resistant and positive for the GFP-vector further generated a more purified 
population of interest.  These ICN1 cells with inhibited Notch-3 expression were given the name 
ICN1-shN3.  HCT-116 cells that were transduced with scrambled shRNA and puromycin 
resistant were derived and used as control 2.    
 
Purified Notch Ligand 
	  
 HCT-116 cells were cultured in the presence of purified Notch ligands.  Culture dishes 
were coated with purified Jagged-1 ligand (purchased from R&D systems) and subsequently 
overlaid with HCT-116 cells.  Proteins were obtained from the lysates of these cells, and 
Western blot analysis was used to identify properties associated with stemness and EMT.   
 
Pharmacologic Inhibition of Notch 
	  
The pharmacologic inhibition of Notch signaling using DAPT (N-[N-(3,5-
Difluorophenacetyl-L-alanyl)]-(S)-phenylglycine t-butyl ester) has been widely studied as a 
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potential therapeutic approach to certain cancers.  DAPT functions to inhibit the work of γ-
secretase, which cleaves the Notch receptors from the cell membrane, thus directly affecting 
Notch signaling.  However, because ICN1 represents the cleaved intracytoplasmic domain of the 
Notch-1 receptor, its expression is not dependent upon γ-secretase function.  Thus, ICN1 
expression is not affected by DAPT treatment. 
  
Protein Isolation  
	  
All cells were grown in complete McCoy’s 5A medium supplemented with 10% FBS and 
1% Penicillin-Streptomycin.  When protein was collected, the cells were released from the 
bottom of the flask by trypsinization, and immediately resuspended in media.  Each cell 
suspension was centrifuged for 10 minutes at 1000 RPM.  The media (supernatant) was then 
aspirated.  A solution of lysis buffer, protease inhibitors (Sigma), and phosphate inhibitors 2 and 
3 (Sigma) was used to break up the pellet containing whole cells by pipetting up and down 
several times.  The cell samples were placed on ice for 30 minutes and vortexed for 30 seconds 
every 5 minutes.  To separate the cell proteins from the rest of the cellular debris, the samples 
were centrifuged at 14,000 RPM for 15 minutes at 4oC.  Then, the supernatant was collected.  




 In order to determine the concentration of the proteins collected in the procedure 
mentioned previously, a BCA (bicinchoninic acid) assay was used.  Serial dilutions of BSA 
(Bovine Serum Albumin) standard and dilutions of the unknown concentration protein collection 
sample were exposed to BCA working reagents (Sigma).  Colorimetric analysis was performed 
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at 750nm using a plate reader.  A standard curve was prepared based on the serial dilutions of the 
BSA standard.  The concentration of each sample was then identified by comparing the sample 
absorbance at 750nm to the standard curve. 
 
 Western Blot Analysis 
 Whole cell lysates were subjected to SDS-polyacrylamide gel electrophoresis and 
subsequently transferred to a PVDF (polyvinylidene fluoride) membrane.  Each protein sample 
of 50 µg was combined with an equal volume of sample buffer (Biorad, Hercules, CA) with 
added reducing agent 2-Mercaptoethanol (Biorad).  The samples were boiled in H2O for 5 
minutes and loaded into a pre-cast 10.5-14% 18-well Tris-HCl (hydrochloric acid) gel (Biorad).  
The protein sample mixtures, as well as a standard Kaleidoscope marker (Biorad) were loaded 
into the gel.   
 The gel was then transferred to a PVDF membrane (Biorad) overnight at 4oC.  Following 
the transfer, the membrane was blocked for 2 hours in a 5% nonfat milk solution in 0.1% TBST 
(Tris-Buffered Saline +Tween 20).  Primary antibody incubation occurred overnight at 4oC.  In 
all experiments, actin protein was used as a loading standard.  The following day, five 
consecutive 10 minute washes in TBST were used to wash the excess primary antibody from the 
membrane.  Then, incubation with the secondary antibody for 2 hours at room temperature.  
Excess secondary antibody was removed by four consecutive 10 minute washes in TBST, 
followed by a single 10 minute wash in TBS.   
 A chemiluminescent substrate (Thermo Scientific, Rockford, IL) was added to the 
membrane and the Western blot was exposed onto an x-ray film.  After developing the film, the 
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Q-scan software program (Biosoft, Cambridge, UK) was used to quantify the individual band 
density. 
Duplication Time Assay 
	  
 For each cell line, 2,000 cells were plated separately into 35 x 10 mm culture dishes 
containing 3 mL of complete media.  After 7 days of growth, each culture was trypsinized to 
completely remove the cells adhered to the bottom of the dish.  The cells were counted manually 
using a hematocytometer as well as using an automated cell counter (Life Technologies).  The 
duplication time of each cell line was determined from these cell counts using the formula  
d = [t (ln (2))] ÷ [ln (NT/No)] where d = duplication time (in hours), t = hours of growth, 
NT=number of cells at the time of counting, and No=number of cells originally plated.    
   
Plating Efficiency 
	  
 Using a FACSVantage SE cell sorter (Becton Dickinson, Franklin Lakes, NJ), a single 
cell along with complete culture media was plated into each well of a 96-well plate.  Each of the 
cell lines HCT 116, ICN1, ICN1-shN3, and controls 1 and 2 were plated onto a separate 96-well 
plate.  After 3 weeks of growth, the number of wells in each plate that contained colonies were 
counted.  To assess cell viability/proliferation, we used a modified protocol from Sigma. Briefly, 
MTT (3-[4,5-dimethylthiazol-2-yl]-2,5- diphenyltetrazolium bromide; thiazolyl blue) (Sigma) 
was dissolved in RPMI-1640 without phenol red (5 mg/ml final concentration). The solution was 
filtered through a 0.2 µm filter and stored at 2–8 °C for frequent use or frozen for extended 
periods. MTT stock solution (5 mg/ml) was added to each culture being assayed to equal one-
tenth the original culture volume and incubated for two hours. At the end of the incubation 
period the converted dye was solubilized with acidic isopropanol (0.04-0.1 N HCl in absolute 
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isopropanol). Absorbance of converted dye was measured at a wavelength of 570 nm with 
background subtraction at 630–690 nm. 
Wound Repair Assay 
	  
 Cells were plated to confluency in culture plates.  Using a 200 µl pipet tip, a single 
scratch was made in each well from the top to the bottom.  Following the initial scratching, the 
width of each scratch was measured in two places using a microscope with an ocular ruler.  After 
24 hours, the scratches were measured again.  The amount of cellular migration or ‘wound 
repair’ was determined by subtracting the second measurement from the first.   
Anchorage Independent Growth assay 
	  
 Equal parts of 1.6% liquid low melting point agarose solution and 2x RPMI media were 
mixed.  1.5 ml of this solution was dispensed into each well of a 12-well culture plate.  This layer 
was then topped with a second layer of 1.5ml that contained equal parts of 0.8% agarose solution 
and 2x RPMI media.  The second layer also contained 1,000 cells.  For each cell line, three wells 
were filled.    
The cells remained in culture at 37oC for 10 days.  On day 10, the cultures were removed 
from the incubator and stained with 125 µl of 2.4 mM MTT (MW 414.32 g).  The MTT stain 




In order to evaluate differences between groups, variables were analyzed using the 
Student’s t-test (Fender et al., 2014).  The Student’s t-test was two-sided and performed using 
Microsoft Excel.  Statistically significant differences between groups were considered to have a 
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Notch-3 Receptor Expression is Regulated by Jagged-1 
 
Previous studies by Fender et al., 2015 have shown that increased expression of the 
Jagged-1 ligand induced by constitutively active Notch-1 was not greatly affected by DAPT (a 
Notch inhibitor) treatment.  However, the increased expression of Slug and CD44 markers in 
ICN1 cells was significantly reduced following the DAPT treatment.  To further explore these 
findings, our group cultured HCT-116 cells in the presence of a purified Notch ligand, Jagged-1.  
Cells were split into three treatment groups:  (1) in the presence of the Jagged-1 ligand alone (2) 
in the presence of the Jagged-1 ligand and DAPT treatment, and (3) neither Jagged-1 ligand nor 
DAPT treatment. 
We found that when the HCT-116 cells were exposed to Jagged-1 ligand alone (1), the 
Notch-3 expression increased by 30% (Fig. 6).  However, when the Jagged-1 ligand and DAPT 
treatments were combined, Notch-3 expression was decreased by 63% (Fig. 6).  Further studies 
ruled out Notch-2 or Notch-4 as playing significant role (data not shown).  Thus, these results 
turned our attention to the Notch-3 receptor as a possible mediator of stemness and EMT in 
Notch signaling, which is the underlying concept of this project.  
 
Generation of the ICN1 and ICN1-shN3 Cell Lines 
	  
In order to further identify the function of the Notch-3 receptor within the previously 
proposed mechanism (Fig. 5), we used the ICN1 and ICN1-shN3 cell lines.  Methodology 
regarding the derivation of ICN1 and ICN1-shN3 cell lines is noted in Methods.  Western blot 
analysis was then performed to ensure the transfection with shRNA for Notch-3 was successful 

















Figure 8.  Detection of Notch-3 Receptor in ICN1-shN3 Cells.    
A Western blot confirms the presence of Notch-3 within the parental HCT-116, controls, and 

















































Morphological Properties of the ICN1 and ICN1-shN3 Cell Lines 
	  
Using the EVOS microscope, images were captured from the HCT-116, ICN1 and ICN1-
shN3 cell lines (Fig. 9).  Morphological distinctions between each of the cell lines are shown.  
The HCT 116 cells are flat and epithelial-like.  Compared to the HCT 116 cells, the ICN1 cells 
are rounder and more spindle-like, indicating a mesenchymal phenotype.  The ICN1-shN3 
cellular morphology suggests a phenotype sharing characteristics with both the HCT 116 and 
ICN1 cell lines.  Expression of the GFP was detected in the ICN1 and ICN1-shN3 cells, but was 
absent from the HCT-116 cells.  
 
Expression of CD44 and Slug Markers in ICN1-shN3 Cells 
Western blot analysis was used to determine the expression of proteins associated with 
stemness and EMT (Fig. 10).  It is evident that there is expression of both CD44 and Slug in the 
ICN1 cells as opposed to the HCT-116 and other control lines.  However, when Notch-3 is 
targeted in the ICN1 cells, the CD44 and Slug expression was eliminated.    
	  
Colony Size and Plating Efficiency of the ICN1-shN3 Cells  
	  
The colonies present were derived from a single cell as explained in Methods.  As shown 
in Figure 11, individually plated ICN-shN3 cells formed the fewest number of overall colonies 
compared to ICN1 and control cells.  In addition to counting the total number of colonies formed 
within each cell line, colony sizes were also determined.  To determine colony size, colony 
dimensions were measured using a microscope with an ocular ruler.  Furthermore, the colony 
size was determined by measuring the optic density in an ELISA reader using the MTT assay.  
Colonies were grouped into three categories based on their optic density [small (<0.1), medium 






















Figure 9.  Morphology of Experimental CRC Cell Lines.   
ICN1-transduced cells and ICN1 cells transduced with Notch-3 shRNA expressing GFP (R1 
region of Figure 2B) were separated from cells negative for GFP expression to form the working 
ICN1 and ICN1-shN3 lines. Images of HCT-116, ICN1 and ICN1-shN3 cells were taken with the 
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Figure 10.  Expression of CD44 and Slug Markers in ICN1-shN3 Cells.   
Western blot analysis using the antibodies CD44 (marker for stemness) and Slug (marker for 
















































Figure 11.  Effect of Notch-3 on Plating Efficiency and Colony Size.   
Single cells from the HCT-116, ICN1, and ICN1-shN3 cell lines were plated into 96-well plates. 
The number of colonies and the colony size were determined after three weeks of culture using 
microscopic analysis and the MTT assay. Colonies were grouped into small, medium or large size.  





















Figure 11.  Effect of Notch-3 on Plating Efficiency and Colony Size.   
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We found that the ICN1-shN3 had the greatest number of small size colonies compared to each 
of the other cell lines (Fig. 11).  Unlike the other cell lines studied, the ICN1-shN3 cells did not 
have any large colonies present.   
 
Duplication Time of ICN1-shN3 Cells 
	  
Assessing the dividing time as described in Methods, we found that the ICN1-shN3 cell 
line had a significantly longer duplication than the parental HCT-116 cells or the other control 
groups (Table 1).   
 
Migration of the ICN1-shN3 Cells 
 
The migratory abilities of the ICN1-shN3 cells were assessed using the wound repair 
assay (Fig. 12).  We observed that the ICN1 cells had a significantly greater wound repair ability 
than the ICN1-shN3 following 24 hours of the initial wound (P<0.05).   
 
Colosphere Formation Ability of the ICN1-shN3 Cells.   
 
In an anchorage-independent assay as described in Methods, cells from lines HCT-116, 
ICN1, ICN1-shN3 and the relative controls were plated on soft agar to prevent adhesion to the 
bottom of the culture dish and to establish an environment conducive to colosphere formation.  
The number of colonies present for each of the cell lines was determined by low power 
microscopy after 10 days of growth.  We found that by targeting the Notch-3 receptor, there was 
a significant decrease in colosphere formation by the ICN1-shN3 cells as compared to the ICN1 
(P<0.01), control, and parental (P<0.05) cell lines (Fig. 13).  Additionally, colosphere formation 
was 2.25-fold higher in ICN1 cells compared to the parental cell line.  This difference was larger 
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(3.5-fold) in medium size colospheres.  Overall, the ICN1-shN3 cells showed a 35% reduction in 












Table 1.  The Effect of Notch-3 on Duplication Time 
 
Duplication time of the HCT-116, controls, ICN1, and ICN1-shN3 cells were calculated after 24 




















































































Figure 12.  The Role of the Notch-3 Receptor in Migration.   
Migration ability of the ICN1 and ICN1-shN3 cells was determined by a wound healing assay. 



























































Figure 13.  Effect of Notch-3 on Anchorage-Independent Growth.   
Soft agar assays with HCT-116, ICN1, ICN1-shN3 and control cell lines were used.  The number 
of colonies formed in an anchorage independent environment was determined for each of the cell 
lines via low power microscopy. Cells were grown for 10 days before being counted.  






























































There is overwhelming evidence that Notch signaling plays a significant role in CRC.  
However, in order to develop new therapies, it is necessary to fully identify the mechanisms of 
Notch signaling and how they are specifically dysregulated in CRC.  In CRC and other cancers, 
both Notch-1 and Notch-3 have been positively associated with poor survival rates, tumor 
formation and resistance, and metastasis (Ozawa et al., 2014). Although it has been found that 
Notch receptor expression (notably Notch-1) is associated with CRC development, little is 
known about Notch-1’s interactions with the other receptors and ligands.  Recently, there has 
been further investigation of the significance of the Notch-3 receptor.  In one particular study, 
Notch-3 is classified as a possible prognostic marker and/or therapeutic target (Ozawa et al., 
2014).  This group later determined that when Notch-1 and Notch-3 were expressed 
simultaneously, there was a significant (P<0.01) decrease in survival rate compared to those who 
did not have both receptors expressed (Ozawa et al., 2014).  This may even suggest that the 
Notch-1 and -3 receptors have an additive role in CRC (Ozawa et al., 2014).  Results from our 
group’s previous studies have also indicated an association between Notch-1 and Notch-3.     
Presently, our group is studying how the Notch-3 receptor mediates Notch-1 induced 
tumorigenesis in HCT-116 human colorectal carcinoma cells.  The ICN1-shN3 cell line, which 
overexpresses ICN1 and is null for the Notch-3 receptor, was constructed to analyze the Notch-3 
receptor specifically (see Methods).  The proposed model (Fig. 5) laid the framework for the 
studies conducted in this project. 
As the process of EMT occurs, the surface and shape of the cell changes dramatically 
upon rearrangement of the cytoskeleton.  It has previously been recorded that cells with 
constitutively active Notch-1 exhibit an altered morphology as compared to the parental cell line 
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(Chappell et al., 2005).  In this particular study, cells with upregulated Notch-1 expression 
exhibited a more rounded morphology, and tended to aggregate in syncytia, whereas the controls 
and parental cells formed hair-like projections of filopodia along the perimeter allowing for 
migration (Chappell et al., 2005).  Upon assessing the morphological properties of the parental 
and ICN1 cell lines in our studies, it was evident that these characteristics agree with the 
published results mentioned above.  The spindle-like, rounded shapes of the ICN1 cell line 
support the claims that upregulated Notch-1 signaling induces stemness.  However, because the 
Notch-3 receptor mediates this mechanism, eliminating it would limit the cell’s morphological 
transformation.  The images obtained of the ICN1-shN3 cells concur with the above findings; the 
morphology of the ICN1-shN3 line appears to reflect a phenotype that shares characteristics of 
both the HCT-116 and the ICN1 cell lines.     
In addition to analysis of morphological traits, the differences in the biochemical 
properties between the ICN1 and ICN1-shN3 cell lines were investigated.  Two notable markers 
of interest are Slug (a transcriptional repressor of E-Cadherin) and CD44 (a cell surface antigen 
involved in tumor metastasis).  Slug prompts the onset of EMT by directly inhibiting the 
transcription of E-Cadherin, a cell-cell adhesion molecule (Shao et al., 2015).  When functional, 
E-Cadherin is responsible for maintaining the epithelial state of the cell and can serve as a tumor 
suppressor (Shao et al., 2015).  In addition to oncogenic properties of Slug, a clear association 
has been established between CD44 expression, the enhancement of EMT, and the invasiveness 
of CRC (Heerboth et al., 2015).  Other studies investigating the role of CD44 have noted that it is 
highly expressed in primary and metastatic CRC and minimally expressed in normal tissues (Cho 
et al., 2012).  Additionally, CD44 interacts closely with cytoskeletal component, and plays an 
influential role in tissue remodeling (i.e. migratory response to injury) (Cho et al., 2012).  These 
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previous reviews have facilitated our interpretation of the Western blot shown in Figure 10.  In 
these results, it is clear that the omission of Notch-3 eliminates the expression of the Slug and 
CD44 markers.  This indicates that the ICN1-induced signaling pathway relies on the function of 
Notch-3 to synthesize these EMT and stemness markers.   
Additional factors contributing to the progression of stemness, EMT, and tumorigenesis 
are cellular evasion of apoptosis and the ability to thrive independent of their tissue of origin.  
When cells become detached or inappropriately positioned within a tissue, anoikis (cell-
detachment-induced-apoptosis) is triggered, which arrests the cell cycle and eventually causes 
caspase-mediated cell death to occur (Guadamillas et al., 2011).  One of the hallmarks of cancer 
cells is developing the ability to overcome anoikis and adapt to an environment other than that of 
their tissue of origin.  The combination of anoikis resistance and anchorage-independence 
permits tumor cells to expand and invade adjacent tissues, travel through the blood stream, and 
take root at a secondary location (Vinson et al., 2015).  In our studies, an anchorage-independent 
assay was performed with the parental, control, ICN1, and ICN1-shN3 cell lines.  The 
colosphere-formation ability of each line was determined by the number of colospheres formed 
in the soft agar after 10 days.  Because we found that the ICN1-shN3 cells had reduced 
colosphere formation ability compared to the controls, parental line, and the ICN1 cells, we were 
able to conclude that the Notch-3 receptor possessed a distinct role in the ability to form 
colospheres.   
Conclusions regarding cellular properties in CRC were formed by studying the single-cell 
proliferation of the parental, controls, ICN1, and ICN1-shN3 cell lines.  The results from the cell 
proliferation assay indicated that the ICN1 cells containing the functional Notch-3 receptor 
formed colonies that were larger in both size and number than the ICN1-shN3 cells.  Thus, we 
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concluded that if the signaling pathway in ICN1 cells is interrupted by blocking the Notch-3 
receptor, a decrease in proliferative capacity will occur. Likewise, the conclusions drawn from 
the dividing time assay results further support the hypothesis.  When the parental and control 
lines were compared to the ICN1-shN3 cells, it was noted that the dividing time was longer for 
those cells lacking the functional Notch-3 receptor.  Longer dividing time is indicative of a less 
aggressive phenotype.  
The assessments of cellular migration and wound healing indicated that the ICN-shN3 
cells showed a decreased ability to heal and regenerate cell growth from the wound site when 
compared to the ICN1 cells.  Combined with the results from the plating efficiency and 
anchorage independent assays, which show that ICN1 cells have an increased tendency over the 
ICN1-shN3 cells to form colonies and colospheres, these assays collectively support the 
proposed mechanism described in Figure 14 that Notch-1-induced tumorigenesis in human 
colorectal carcinoma cells is mediated by Notch-3.    
For over a decade, the Notch signaling pathway has been a focus in CRC research 
(Ntziacristos et al., 2014).  However, given that the pathway is responsible for normal tissue 
differentiation and regeneration, generating a therapy targeting only the cancerous cells poses a 
significant challenge (Ntziacristos et al., 2014).  Future directions in developing Notch-targeted 
therapies for CRC will rely on developing a complete understanding of the Notch mechanism.  In 
particular, further identifying the specificity of Notch receptors and ligands, their downstream 
targets, as well as the surrounding microenvironment, will enable therapies to use antibodies and 


















Figure 14.  Proposed Model  
Notch-1 signal upregulates the Jagged-1 ligand, which in turn activates the Notch-3 receptor, 
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